The problem of strict image-based inclusion criteria for mechanical thrombectomy – an analysis of stroke patients with an initial low CBV-ASPECTS score

Abstract

Introduction

Endovascular treatment for acute ischaemic stroke with large artery occlusion has become the standard of care. However, the question if a subgroup of patients, with a low cerebral blood volume Alberta Stroke Program Early CT score (CBV-ASPECTS) ≤ 7 should be excluded from endovascular treatment remains open. Therefore; we investigated the difference of outcome between patients who were treated by endovascular treatment vs patients who did not receive endovascular treatment.

Methods

We retrospectively analysed our stroke database for all patients who presented within six hours of onset with unfavourable imaging findings and who received endovascular treatment or best medical treatment alone. Unfavourable imaging was defined as a CBV-ASPECTS ≤ 7, which was an exclusion criterion for endovascular treatment at our institution before 2015.

Results

From 60 patients with an initial CBV-ASPECTS ≤ 7, 40 received best medical treatment and 20 were treated with endovascular treatment. Arterial hypertension and atrial fibrillation was more present in patients without endovascular treatment, the other baseline characteristics and percentage of patients treated with intravenous recombinant tissue plasminogen activator were not significantly different in both groups. At discharge, 40% of the interventional treated patients had a favourable outcome (eight of 20 (40%) vs six of 40 (15%; p = 0.031). The median values of the National Institute of Health Stroke Score and modified Rankin Scale at discharge were significantly lower in the treated cohort (6.5 (2.5–10.5) vs 16 (9.5–22.5); p = 0.006; 3 (0–5.5) vs 5 (4.5–5.5); p = 0.003).

Conclusion

Patients with a CBV-ASPECTS ≤ 7 are likely to benefit from therapy and therefore may not be excluded from endovascular treatment. Further randomised trials are warranted to validate the data.

Keywords

Endovascular treatment Alberta Stroke Program Early CT Score acute stroke outcome

Get full access to this article

View all access options for this article.

References

del Zoppo

Higashida

Furlan

et al.

PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998; 29: 4–11.

Berkhemer

Fransen

PSS

Beumer

et al.

A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2014; 372: 11–20.

Goyal

Demchuk

Menon

et al.

Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019–1030.

Campbell

BC V

Mitchell

Kleinig

et al.

Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009–1018.

Jovin

Chamorro

Cobo

et al.

Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296–2306.

Saver

Goyal

Bonafe

et al.

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285–2295.

Goyal

Menon

van Zwam

et al.

Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet 2017; 387: 1723–1731.

Saver

Goyal

van der Lugt

et al.

Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: A meta-analysis. JAMA 2016; 316: 1279–1289.

Nogueira

Jadhav

Haussen

et al.

Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. Epub ahead of print 11 November 2017. DOI: 10.1056/NEJMoa1706442.

10.

Hill

Rowley

Adler

et al.

Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003; 34: 1925–1931.

11.

Tsogkas

Knauth

Schregel

et al.

Added value of CT perfusion compared to CT angiography in predicting clinical outcomes of stroke patients treated with mechanical thrombectomy. Eur Radiol 2016; 26: 4213–4219.

12.

Broderick

Palesch

Demchuk

et al.

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893–903.

13.

Kidwell

Jahan

Gornbein

et al.

A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914–923.

14.

Ciccone

Valvassori

Nichelatti

et al.

Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904–913.

15.

Psychogios

M-N

Schramm

Frölich

et al.

Alberta Stroke Program Early CT scale evaluation of multimodal computed tomography in predicting clinical outcomes of stroke patients treated with aspiration thrombectomy. Stroke 2013; 44: 2188–2193.

16.

Psychogios

M-N

Knauth

Bshara

et al.

Computed tomography perfusion-based selection of endovascularly treated acute ischaemic stroke patients – are there lessons to be learned from the pre-evidence era?

Neuroradiol J 2017; 30: 138–143.

17.

Yoo

Berkhemer

Fransen

PSS

et al.

Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: A subgroup analysis of a randomised phase 3 trial (MR CLEAN). Lancet Neurol 2017; 15: 685–694.

18.

Maus

Behme

Kabbasch

et al.

Maximizing first-pass complete reperfusion with SAVE. Clin Neuroradiol. Epub ahead of print 13 February 2017. DOI: 10.1007/s00062-017-0566-z.

19.

Möhlenbruch

Kabbasch

Kowoll

et al.

Multicenter experience with the new SOFIA Plus catheter as a primary local aspiration catheter for acute stroke thrombectomy. J Neurointerv Surg 2017; 9: 1223–1227.

20.

Maier

Behme

Schnieder

et al.

Early computed tomography-based scores to predict decompressive hemicraniectomy after endovascular therapy in acute ischemic stroke. PLoS One 2017; 12: 1–12.

21.

Psychogios

M-N

Behme

Schregel

et al.

One-stop management of acute stroke patients. Stroke 2017; 48: 3152–3155.